| Q39243997 | A population-based study of selected demographic characteristics of Israeli-Jewish women with cervical squamous cell carcinoma |
| Q92311837 | Association of TLR4 and TLR9 gene polymorphisms and haplotypes with cervicitis susceptibility |
| Q81161584 | COX-2 overexpression as a biomarker of early cervical carcinogenesis: a pilot study |
| Q28755868 | Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting |
| Q34029941 | Human papillomavirus (HPV) vaccine policy and evidence-based medicine: are they at odds? |
| Q89997049 | Human papillomavirus and cervical cancer |
| Q36557818 | Parity as a cofactor for high-grade cervical disease among women with persistent human papillomavirus infection: a 13-year follow-up |
| Q35038699 | Placenta growth factor promotes migration through regulating epithelial-mesenchymal transition-related protein expression in cervical cancer |
| Q40905270 | Risk factors for treatment failure following cold coagulation cervical treatment for CIN pathology: a cohort-based study. |
| Q92256596 | The potential of RNA as a target for national screening of pre-cancer |
| Q38555725 | The safety of human papilloma virus-blockers and the risk of triggering autoimmune diseases |
| Q36501064 | Vaginal cells of smokers are more resistant to human papillomavirus infection than that of non-smokers |